Bengaluru, India

Sudhir Landge

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mmv Medicines for Malaria Venture. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sudhir Landge. Retrieved from https://idiyas.com/inventor/sudhir-landge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sudhir Landge: Innovator in Malaria Treatment

Introduction

Sudhir Landge is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for malaria. His work is crucial in addressing a disease that affects millions worldwide.

Latest Patents

Sudhir Landge holds a patent for "Triaminopyrimidine compounds useful for preventing or treating malaria." This invention relates to triaminopyrimidines and their pharmaceutically acceptable salts. It focuses on their use in the treatment and prevention of malaria caused by various species, along with methods of preparation.

Career Highlights

Sudhir Landge is associated with Medicines for Malaria Venture, an organization dedicated to the development of new medicines for malaria. His role in this organization highlights his commitment to advancing healthcare solutions.

Collaborations

He has collaborated with notable colleagues, including Shahul Hameed Peer Mohamed and Vikas Patil. These partnerships enhance the research and development efforts in the fight against malaria.

Conclusion

Sudhir Landge's innovative work in developing triaminopyrimidine compounds represents a significant advancement in malaria treatment. His contributions are vital in the ongoing battle against this global health challenge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…